Federated Hermes’s ImageneBio Inc IMA Stock Holding History

Federated Hermes’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-204	Closed	-$1.66K	–	2137
2025 Q3	$1.66K	Buy	+204	New	+$2.7K	﹤0.01%	2046

Other funds holding IMA

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Federated Hermes's IMA Position: Q4 2025 in Review

Federated Hermes sold out of ImageneBio Inc (IMA) in Q4 2025, closing a stake of 204 shares — an estimated $1.66K sold.

Federated Hermes first reported a position in IMA in Q3 2025 and held it in 1 quarter. The position peaked at $1.66K in Q3 2025. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

Federated Hermes reported no remaining ImageneBio Inc position as of Q4 2025 after selling out during the quarter.
Federated Hermes sold 204 ImageneBio Inc shares in Q4 2025, an estimated $1.66K.
Federated Hermes first reported a position in ImageneBio Inc in Q3 2025 and held it in 1 quarter.
Federated Hermes's ImageneBio Inc position peaked at $1.66K in Q3 2025.
41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.